Presented by: National Forum for Heart Disease and Stroke Prevention Improving Hypertension Control The Kaiser Permanente Hypertension Control Project:

Slides:



Advertisements
Similar presentations
Get to Goal, Achieve Control
Advertisements

Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Multinational Comparisons of Health Systems Data, 2007 Bianca K. Frogner, Meghan Bishop, and Gerard F. Anderson, Ph.D. Johns Hopkins University November.
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
International Society for Heart and Lung Transplantation 2010 Annual Report International Society for Heart and Lung Transplantation: A Forum that Includes.
J Heart Lung Transplant 2009;28: HEART TRANSPLANTATION Pediatric Recipients ISHLT 2009.
EMR Use is Not Associated with Better Diabetes Care Patrick J OConnor, MD, MPH Stephen E Asche, MA A Lauren Crain, PhD Leif I Solberg, MD William A Rush,
Paying for Care Coordination Gerard Anderson, PhD Johns Hopkins University.
Behavioral health disorders are common.
National Scorecard, 2008: Chartpack This Chartpack presents data for all indicators scored in the National Scorecard on U.S. Health System Performance,
Cardiovascular Disease (CVD) in Texas Philip Huang, MD, MPH Texas Department of State Health Services.
Promising Practices Related To The Prevention, Control and Treatment of Hypertension David J. Hyman, MD, MPH Professor of Medicine and Family & Community.
Randall M. Zusman, MD Associate Professor of Medicine
1 Exploration of Health Care Providers Behavior to Keep Their Revenues after Reduction of Payment Generosity --- A Case of Drug Payment in Taiwan Likwang.
Reduced Incidence of ESRD among 60 to 80–year-olds in Denmark Heaf JG 1, Wehberg S 2, Engberg H 2 Danish Nephrology Registry 1 Herlev Hospital, University.
Nurse Led Clinics Opportunity for nurses to make a difference Wilma Scholte op Reimer, RN, PhD Amsterdam School of Health Professions Academic Medical.
CE REVIEW UNDERSTANDING HYPERTENSION. Hypertension is a chronic medical condition affecting more than 65 million Americans. Controlling hypertension is.
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction Robert W. Yeh, MD MSc Massachusetts General Hospital Alan S. Go, MD Kaiser.
INFANT MORTALITY FOLLOW-UP ALABAMA 2005 ALABAMA DEPARTMENT OF PUBLIC HEALTH CENTER FOR HEALTH STATISTICS.
ADVANCING HEALTH CARE QUALITY IN 2007 AND BEYOND Margaret E. O’Kane President, NCQA.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Preventing Strokes One at a Time Acute Interventions and Management 2009.
JNC 8 Guidelines….
The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure
Primary care of hypertensive patients and the risk of acute events Irina Stirbu-Wagner Markus MJ Nielen Maaike Langelaan Robert A. Verheij Joke C. Korevaar.
Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
Successful Approaches to Reduce Hypertension Stephen Sidney, MD, MPH Kaiser Permanente Northern California October 17, 2012.
Cardiovascular Disease Casey Haberl LIF
Use of ACE Inhibitors in Pregnant Women and the Risk of Congenital Heart Defects De-Kun Li, MD, PhD Division of Research Kaiser Permanente Northern California.
TRANSLATING VISITS INTO PATIENTS USING AMBULATORY VISIT DATA (Hypertensive patient case study) by Esther Hing, M.P.H. and Julia Holmes, Ph.D U.S. DEPARTMENT.
Leveraging IT to Transform Health AcademyHealth Delivery System Meeting – Transforming Health and Health Care June 21, 2013 Amy Compton-Phillips, MD Associate.
Peter Emery, MD Specialist in Clinical Hypertension InterMed Portland, ME.
10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.
UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,
IMPACT OF AN ESSENTIAL DRUGS LIST AND TREATMENT GUIDELINES ON PRESCRIBING IN SOUTH AFRICA In 1998 the National Department of Health (NDOH) published standard.
Federal Study of Adherence to Medications (FAME) Trial Presented at The American Heart Association Annual Scientific Session 2006 Presented by Dr. Allen.
Chronic Care Challenge Initiative. All AMGA member medical groups and health systems agreed to work together to address one of the nation’s most important.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
3 rd Annual Right Care Summit October 1 st, 2010 Stephen M. Shortell Ph.D., M.P.H. Dean, University of California, Berkeley, School of Public Health.
Blood Pressure Control 13th Annual Meeting - National Forum for Heart Disease and Stroke Prevention October 21, 2015 Cindy Ferrara, RN, MS Essentia Health.
Pre-ALLHAT Drug Use IMS Health NDTI, Year % of Treated Patients on Medication CCBs Beta Blockers Diuretics ACE Inhibitors.
Wise Ones Coli Clements, Megan Kamil, Kerri Spilker.
HYPERTENSION SUMMIT. Hypertension Epidemiology Prevalence of Hypertension worldwide: – 1 Billion Deaths worldwide: – 7 million per year In USA, 90% lifetime.
A Randomized Trial of Intensive versus Standard Blood-Pressure Control The SPRINT Research Group* November 9, /NEJMoa R2 이성곤 /pf. 우종신.
Internal Medicine Workshop Series Laos September /October 2009.
Drugs for Hypertension
Management of Hypertension according to JNC 7
Hypertension In The Stroke Patient
Systemic Implementation Strategies to Improve Hypertension: The Kaiser Permanente Southern California Experience  John J. Sim, MD, Joel Handler, MD, Steven.
JNC VIII Hypertension.
Hypertension JNC VIII Guidelines.
Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.
Copyright © 2013 American Medical Association. All rights reserved.
Isolated Systolic Hypertension: An Update After SPRINT
Hypertension: A Risk Factor For Stroke
Thinking Beyond New Clinical Guidelines: Update in Hypertension
Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks  Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.
RCHC’s Cardiovascular Health Initiative
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Volume 72, Issue 12, Pages (December 2007)
Isolated Systolic Hypertension: An Update After SPRINT
Internal Medicine Workshop Series Laos September /October 2009
KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
K. A. Su,1,2 L. A. Habel,3 N. S. Achacoso,3 G. D. Friedman,3 M. M
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.
Presentation transcript:

Presented by: National Forum for Heart Disease and Stroke Prevention Improving Hypertension Control The Kaiser Permanente Hypertension Control Project: How a large health care organization improved blood pressure control from 44% to 80% in 8 years Marc Jaffe, MD Clinical Leader, Kaiser Permanente Northern California Cardiovascular Risk Reduction Program Associate Clinical Professor of Medicine, UCSF October 17, 2012

2 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Kaiser Permanente Northern California (KPNC) 3.3 million members 2.7 million adults >5,000 MDs 17 medical centers 35 outpatient facilities

3 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 KPNC Hypertension Implementation Timeline Guideline Created, updated every 2 yrs 2002 Performance Measures Distributed Successful practices disseminated 2005 Single Pill Combination Promoted 2007 Non-MD BP Visits 2000 HTN Registry developed

4 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Evolution of the Hypertension Guideline Year2001* Step 1 TD or BBTDTD or TD + ACEI TD or TD + ACEI TD or TD + ACEI Step 2 TD + BBTD + ACEI or TD + BB TD + ACEI Step 3 TD + BB + ACEI TD + BB + ACEI TD + ACEI + BB TD + ACEI + BB TD + ACEI + DCCB Step 4 TD + BB + ACEI + DCCB TD + BB + ACEI + DCCB TD + BB + ACEI + DCCB TD + BB + ACEI + DCCB TD + ACEI + DCCB + BB or Spir TD=Thiazide Diuretic, BB=Beta Blocker, ACEI=Angiotensin Converting Enzyme Inhibitor, DCCB=Dihydropyridine Calcium Channel Blocker, Spir=Spironolactone* No Significant changes after step 2

5 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Evolution of the Hypertension Guideline Year2001* Step 1 TD or BBTDTD or TD + ACEI TD or TD + ACEI TD or TD + ACEI Step 2 TD + BBTD + ACEI or TD + BB TD + ACEI Step 3 TD + BB + ACEI TD + BB + ACEI TD + ACEI + BB TD + ACEI + BB TD + ACEI + DCCB Step 4 TD + BB + ACEI + DCCB TD + BB + ACEI + DCCB TD + BB + ACEI + DCCB TD + BB + ACEI + DCCB TD + ACEI + DCCB + BB or Spir TD=Thiazide Diuretic, BB=Beta Blocker, ACEI=Angiotensin Converting Enzyme Inhibitor, DCCB=Dihydropyridine Calcium Channel Blocker, Spir=Spironolactone.* No Significant changes after step 2 BB not 1 st ACEI or BB 2 nd SPC OK 1 st ACEI 2 nd BB 3 rd DCCB 3 nd BB OK 4 th BB OK 1 st BB OK 2 nd BB 3 rd BB still 3 rd BB OK 4 th

6 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Hypertension Registry Development Outpatient Coding HTN Registry: Lab Results Medications Demographics Comorbid Conditions BP Measurements Visit Information Hospital Pharmacy Membership Data Clinical Laboratory Outpatient EMR

7 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Hypertension Registry Definition  Hypertension (HTN) Registry Population:  2 visits for HTN in the past 2 yrs  No age limits  Designed to be very inclusive

8 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Hypertension Control Definition  Hypertension Control Rate  Age yrs with an encounter diagnosis of Hypertension (46-85 before 2006) in the 1 st 6 months of the reporting year  Blood Pressure at last clinic visit <140/90 (≤140/90 before 2006)  Exclusions: End Stage Renal Disease, Renal Transplant, pregnancy, or blood pressure measurements during hospitalization, Emergency Department visit, diagnostic test, or surgical procedure.

9 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Medical Center Hypertension Control 2001 Performance Reports Distributed to Medical Directors Quarterly Report , Monthly after 2007 High Performing sites identified and practices shared

10 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Evolution of Single Pill Combination Therapy in KPNC Not generally advised Advised Optional

11 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 1/4 of ACEI Rx ’ s dispensed as Single Pill Combination Therapy

12 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Non-MD Blood Pressure Check BP at goal Doctor clinic visit BP over goal Follow up non-MD visit Treatment intensification BP check Advantages Shorter visit for patient No charge for visit Scheduling flexibility Improves access to MD

13 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Hypertension Control Rates Commercial Rate as reported to HEDIS 44% 80%

14 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Hypertension Control Rates in Kaiser Permanent Northern California Commercial Rate as reported to HEDIS

15 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Hypertension Results  From 2001 to 2009 in KPNC  HTN control rate nearly doubled from 44% to 80%  HTN registry increased by 167%  Controlled HTN tripled from 171,000 to 531,000  359,00 more people had controlled HTN  6 care processes implemented  Evidence Based Guideline development  HTN Registry creation  Performance measure distribution  Successful practice dissemination  Single Pill Combination therapy promotion  Non-physician BP visit creation

16 Marc Jaffe, MD The Permanente Medical Group, Inc. Oakland, CA 10/11/2014 Heart Attack Rates are declining in KPNC 16